nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—SLC6A2—locus ceruleus—epilepsy syndrome	0.0421	0.26	CbGeAlD
Bretylium—SLC6A2—autonomic nervous system—epilepsy syndrome	0.0224	0.138	CbGeAlD
Bretylium—SLC6A2—ganglion—epilepsy syndrome	0.0124	0.0769	CbGeAlD
Bretylium—ATP1A1—hindbrain—epilepsy syndrome	0.0106	0.0656	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—SIX3—epilepsy syndrome	0.00941	0.0691	CbGpPWpGaD
Bretylium—Edrophonium—BCHE—epilepsy syndrome	0.00937	1	CrCbGaD
Bretylium—ATP1A1—Preimplantation Embryo—FOSB—epilepsy syndrome	0.0086	0.0632	CbGpPWpGaD
Bretylium—ATP1A1—brainstem—epilepsy syndrome	0.00609	0.0376	CbGeAlD
Bretylium—ATP1A1—forebrain—epilepsy syndrome	0.00587	0.0363	CbGeAlD
Bretylium—SLC6A2—brainstem—epilepsy syndrome	0.00541	0.0334	CbGeAlD
Bretylium—ATP1A1—telencephalon—epilepsy syndrome	0.0054	0.0334	CbGeAlD
Bretylium—SLC6A2—forebrain—epilepsy syndrome	0.00522	0.0322	CbGeAlD
Bretylium—SLC6A2—telencephalon—epilepsy syndrome	0.0048	0.0297	CbGeAlD
Bretylium—ATP1A1—Ion channel transport—CLCN6—epilepsy syndrome	0.00464	0.0341	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—CLCN2—epilepsy syndrome	0.00464	0.0341	CbGpPWpGaD
Bretylium—ATP1A1—medulla oblongata—epilepsy syndrome	0.00424	0.0262	CbGeAlD
Bretylium—SLC6A2—Monoamine Transport—SYN1—epilepsy syndrome	0.00397	0.0291	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP2A2—epilepsy syndrome	0.00394	0.0289	CbGpPWpGaD
Bretylium—ATP1A1—midbrain—epilepsy syndrome	0.00388	0.024	CbGeAlD
Bretylium—ATP1A1—spinal cord—epilepsy syndrome	0.00378	0.0234	CbGeAlD
Bretylium—SLC6A2—medulla oblongata—epilepsy syndrome	0.00377	0.0233	CbGeAlD
Bretylium—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—epilepsy syndrome	0.00368	0.027	CbGpPWpGaD
Bretylium—ATP1A1—head—epilepsy syndrome	0.00336	0.0208	CbGeAlD
Bretylium—ATP1A1—nervous system—epilepsy syndrome	0.00319	0.0197	CbGeAlD
Bretylium—ATP1A1—central nervous system—epilepsy syndrome	0.00307	0.019	CbGeAlD
Bretylium—ATP1A1—cerebellum—epilepsy syndrome	0.003	0.0185	CbGeAlD
Bretylium—ATP1A1—Ion channel transport—GABRG2—epilepsy syndrome	0.00299	0.022	CbGpPWpGaD
Bretylium—SLC6A2—head—epilepsy syndrome	0.00299	0.0185	CbGeAlD
Bretylium—SLC6A2—nervous system—epilepsy syndrome	0.00283	0.0175	CbGeAlD
Bretylium—SLC6A2—central nervous system—epilepsy syndrome	0.00273	0.0169	CbGeAlD
Bretylium—SLC6A2—Amine compound SLC transporters—SLC6A1—epilepsy syndrome	0.00255	0.0187	CbGpPWpGaD
Bretylium—ATP1A1—brain—epilepsy syndrome	0.00244	0.0151	CbGeAlD
Bretylium—SLC6A2—Monoamine Transport—SLC6A1—epilepsy syndrome	0.00242	0.0178	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—HRH3—epilepsy syndrome	0.00238	0.0175	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—GABRA5—epilepsy syndrome	0.00227	0.0166	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—GABRA1—epilepsy syndrome	0.00217	0.0159	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—GABRB3—epilepsy syndrome	0.00217	0.0159	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ARHGEF9—epilepsy syndrome	0.00217	0.0159	CbGpPWpGaD
Bretylium—SLC6A2—brain—epilepsy syndrome	0.00217	0.0134	CbGeAlD
Bretylium—SLC6A2—Monoamine Transport—SLC6A4—epilepsy syndrome	0.00194	0.0142	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—GABRB2—epilepsy syndrome	0.00193	0.0141	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—TRPV1—epilepsy syndrome	0.00185	0.0136	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TH—epilepsy syndrome	0.00173	0.0127	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—NOS1—epilepsy syndrome	0.00173	0.0127	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00162	0.0119	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00162	0.0119	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00147	0.0108	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00144	0.0106	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00144	0.0106	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00144	0.0106	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP2A2—epilepsy syndrome	0.00136	0.01	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.00132	0.00967	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00123	0.009	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00123	0.009	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00123	0.009	CbGpPWpGaD
Bretylium—Hypertension—Zonisamide—epilepsy syndrome	0.00121	0.00175	CcSEcCtD
Bretylium—Vertigo—Phenytoin—epilepsy syndrome	0.00121	0.00174	CcSEcCtD
Bretylium—Dizziness—Phenobarbital—epilepsy syndrome	0.00121	0.00174	CcSEcCtD
Bretylium—Syncope—Phenytoin—epilepsy syndrome	0.0012	0.00174	CcSEcCtD
Bretylium—Dyspnoea—Propofol—epilepsy syndrome	0.0012	0.00174	CcSEcCtD
Bretylium—Vertigo—Oxcarbazepine—epilepsy syndrome	0.0012	0.00173	CcSEcCtD
Bretylium—Feeling abnormal—Acetazolamide—epilepsy syndrome	0.0012	0.00173	CcSEcCtD
Bretylium—Syncope—Oxcarbazepine—epilepsy syndrome	0.0012	0.00173	CcSEcCtD
Bretylium—Anxiety—Zonisamide—epilepsy syndrome	0.00119	0.00172	CcSEcCtD
Bretylium—Shock—Diazepam—epilepsy syndrome	0.00119	0.00172	CcSEcCtD
Bretylium—Dizziness—Rufinamide—epilepsy syndrome	0.00118	0.00171	CcSEcCtD
Bretylium—Loss of consciousness—Phenytoin—epilepsy syndrome	0.00118	0.00171	CcSEcCtD
Bretylium—Confusional state—Felbamate—epilepsy syndrome	0.00118	0.0017	CcSEcCtD
Bretylium—Dyspnoea—Midazolam—epilepsy syndrome	0.00118	0.0017	CcSEcCtD
Bretylium—Loss of consciousness—Oxcarbazepine—epilepsy syndrome	0.00117	0.0017	CcSEcCtD
Bretylium—Hyperhidrosis—Diazepam—epilepsy syndrome	0.00117	0.00169	CcSEcCtD
Bretylium—Lethargy—Topiramate—epilepsy syndrome	0.00116	0.00168	CcSEcCtD
Bretylium—Vomiting—Phenobarbital—epilepsy syndrome	0.00116	0.00168	CcSEcCtD
Bretylium—Hypertension—Phenytoin—epilepsy syndrome	0.00116	0.00168	CcSEcCtD
Bretylium—Confusional state—Zonisamide—epilepsy syndrome	0.00116	0.00167	CcSEcCtD
Bretylium—Hypertension—Oxcarbazepine—epilepsy syndrome	0.00115	0.00167	CcSEcCtD
Bretylium—Vertigo—Carbamazepine—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—Bradycardia—Valproic Acid—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.00115	0.00845	CbGpPWpGaD
Bretylium—Diarrhoea—Lacosamide—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—Syncope—Carbamazepine—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—Body temperature increased—Acetazolamide—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—Anxiety—Clonazepam—epilepsy syndrome	0.00115	0.00166	CcSEcCtD
Bretylium—Sweating increased—Gabapentin—epilepsy syndrome	0.00114	0.00165	CcSEcCtD
Bretylium—Angina pectoris—Gabapentin—epilepsy syndrome	0.00114	0.00165	CcSEcCtD
Bretylium—Vomiting—Rufinamide—epilepsy syndrome	0.00114	0.00164	CcSEcCtD
Bretylium—Anxiety—Oxcarbazepine—epilepsy syndrome	0.00113	0.00164	CcSEcCtD
Bretylium—Hyperhidrosis—Felbamate—epilepsy syndrome	0.00113	0.00163	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—TSC2—epilepsy syndrome	0.00113	0.00829	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—AGT—epilepsy syndrome	0.00113	0.00828	CbGpPWpGaD
Bretylium—Loss of consciousness—Carbamazepine—epilepsy syndrome	0.00113	0.00163	CcSEcCtD
Bretylium—Shock—Zonisamide—epilepsy syndrome	0.00113	0.00163	CcSEcCtD
Bretylium—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.00112	0.00162	CcSEcCtD
Bretylium—Affect lability—Topiramate—epilepsy syndrome	0.00112	0.00162	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00112	0.00823	CbGpPWpGaD
Bretylium—Diarrhoea—Clobazam—epilepsy syndrome	0.00112	0.00161	CcSEcCtD
Bretylium—Psychotic disorder—Topiramate—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Vertigo—Lamotrigine—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Feeling abnormal—Propofol—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Confusional state—Clonazepam—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Dizziness—Lacosamide—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Syncope—Lamotrigine—epilepsy syndrome	0.00111	0.00161	CcSEcCtD
Bretylium—Conjunctivitis—Pregabalin—epilepsy syndrome	0.00111	0.0016	CcSEcCtD
Bretylium—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.00111	0.0016	CcSEcCtD
Bretylium—Hypertension—Carbamazepine—epilepsy syndrome	0.00111	0.0016	CcSEcCtD
Bretylium—Confusional state—Phenytoin—epilepsy syndrome	0.00111	0.0016	CcSEcCtD
Bretylium—Confusional state—Oxcarbazepine—epilepsy syndrome	0.0011	0.00159	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.00109	0.00801	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.00109	0.00801	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.00109	0.00801	CbGpPWpGaD
Bretylium—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.00109	0.00157	CcSEcCtD
Bretylium—Feeling abnormal—Midazolam—epilepsy syndrome	0.00109	0.00157	CcSEcCtD
Bretylium—Anxiety—Carbamazepine—epilepsy syndrome	0.00109	0.00157	CcSEcCtD
Bretylium—Nausea—Phenobarbital—epilepsy syndrome	0.00108	0.00157	CcSEcCtD
Bretylium—Mood swings—Topiramate—epilepsy syndrome	0.00108	0.00156	CcSEcCtD
Bretylium—Dizziness—Clobazam—epilepsy syndrome	0.00108	0.00156	CcSEcCtD
Bretylium—Shock—Phenytoin—epilepsy syndrome	0.00108	0.00156	CcSEcCtD
Bretylium—Dyspnoea—Diazepam—epilepsy syndrome	0.00108	0.00156	CcSEcCtD
Bretylium—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.00108	0.00155	CcSEcCtD
Bretylium—Shock—Oxcarbazepine—epilepsy syndrome	0.00107	0.00155	CcSEcCtD
Bretylium—Hypertension—Lamotrigine—epilepsy syndrome	0.00107	0.00155	CcSEcCtD
Bretylium—Vomiting—Lacosamide—epilepsy syndrome	0.00107	0.00154	CcSEcCtD
Bretylium—Abdominal pain—Propofol—epilepsy syndrome	0.00107	0.00154	CcSEcCtD
Bretylium—Body temperature increased—Propofol—epilepsy syndrome	0.00107	0.00154	CcSEcCtD
Bretylium—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.00107	0.00154	CcSEcCtD
Bretylium—Nausea—Rufinamide—epilepsy syndrome	0.00106	0.00154	CcSEcCtD
Bretylium—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.00106	0.00153	CcSEcCtD
Bretylium—Confusional state—Carbamazepine—epilepsy syndrome	0.00106	0.00152	CcSEcCtD
Bretylium—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.00105	0.00152	CcSEcCtD
Bretylium—Anxiety—Lamotrigine—epilepsy syndrome	0.00105	0.00152	CcSEcCtD
Bretylium—Dyspnoea—Felbamate—epilepsy syndrome	0.00104	0.00151	CcSEcCtD
Bretylium—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.00104	0.0015	CcSEcCtD
Bretylium—Bradycardia—Pregabalin—epilepsy syndrome	0.00104	0.0015	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00104	0.00764	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00104	0.00764	CbGpPWpGaD
Bretylium—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.00104	0.0015	CcSEcCtD
Bretylium—Vomiting—Clobazam—epilepsy syndrome	0.00104	0.0015	CcSEcCtD
Bretylium—Abdominal pain—Levetiracetam—epilepsy syndrome	0.00103	0.00149	CcSEcCtD
Bretylium—Body temperature increased—Levetiracetam—epilepsy syndrome	0.00103	0.00149	CcSEcCtD
Bretylium—Shock—Carbamazepine—epilepsy syndrome	0.00103	0.00149	CcSEcCtD
Bretylium—Dyspnoea—Zonisamide—epilepsy syndrome	0.00102	0.00147	CcSEcCtD
Bretylium—Confusional state—Lamotrigine—epilepsy syndrome	0.00102	0.00147	CcSEcCtD
Bretylium—Conjunctivitis—Gabapentin—epilepsy syndrome	0.00102	0.00147	CcSEcCtD
Bretylium—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.00101	0.00146	CcSEcCtD
Bretylium—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.00101	0.00146	CcSEcCtD
Bretylium—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.001	0.00145	CcSEcCtD
Bretylium—Nausea—Lacosamide—epilepsy syndrome	0.000999	0.00144	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	0.000998	0.00733	CbGpPWpGaD
Bretylium—Feeling abnormal—Diazepam—epilepsy syndrome	0.000996	0.00144	CcSEcCtD
Bretylium—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000996	0.00144	CcSEcCtD
Bretylium—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000995	0.00144	CcSEcCtD
Bretylium—Shock—Lamotrigine—epilepsy syndrome	0.000995	0.00144	CcSEcCtD
Bretylium—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000989	0.00143	CcSEcCtD
Bretylium—Dyspnoea—Clonazepam—epilepsy syndrome	0.000984	0.00142	CcSEcCtD
Bretylium—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000978	0.00141	CcSEcCtD
Bretylium—Dyspnoea—Phenytoin—epilepsy syndrome	0.000978	0.00141	CcSEcCtD
Bretylium—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000973	0.0014	CcSEcCtD
Bretylium—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000971	0.0014	CcSEcCtD
Bretylium—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000971	0.0014	CcSEcCtD
Bretylium—Nausea—Clobazam—epilepsy syndrome	0.00097	0.0014	CcSEcCtD
Bretylium—Feeling abnormal—Felbamate—epilepsy syndrome	0.000964	0.00139	CcSEcCtD
Bretylium—Dizziness—Acetazolamide—epilepsy syndrome	0.000962	0.00139	CcSEcCtD
Bretylium—Sweating increased—Topiramate—epilepsy syndrome	0.00096	0.00139	CcSEcCtD
Bretylium—Angina pectoris—Topiramate—epilepsy syndrome	0.00096	0.00139	CcSEcCtD
Bretylium—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000957	0.00138	CcSEcCtD
Bretylium—Abdominal pain—Diazepam—epilepsy syndrome	0.000956	0.00138	CcSEcCtD
Bretylium—Bradycardia—Gabapentin—epilepsy syndrome	0.000955	0.00138	CcSEcCtD
Bretylium—Flushing—Pregabalin—epilepsy syndrome	0.000949	0.00137	CcSEcCtD
Bretylium—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000944	0.00136	CcSEcCtD
Bretylium—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000937	0.00135	CcSEcCtD
Bretylium—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000933	0.00135	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000929	0.00682	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000929	0.00682	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000929	0.00682	CbGpPWpGaD
Bretylium—Body temperature increased—Felbamate—epilepsy syndrome	0.000925	0.00134	CcSEcCtD
Bretylium—Abdominal pain—Felbamate—epilepsy syndrome	0.000925	0.00134	CcSEcCtD
Bretylium—Vomiting—Acetazolamide—epilepsy syndrome	0.000925	0.00134	CcSEcCtD
Bretylium—Diarrhoea—Propofol—epilepsy syndrome	0.000925	0.00133	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—TXNRD1—epilepsy syndrome	0.00092	0.00675	CbGpPWpGaD
Bretylium—Feeling abnormal—Clonazepam—epilepsy syndrome	0.00091	0.00131	CcSEcCtD
Bretylium—Body temperature increased—Zonisamide—epilepsy syndrome	0.000906	0.00131	CcSEcCtD
Bretylium—Abdominal pain—Zonisamide—epilepsy syndrome	0.000906	0.00131	CcSEcCtD
Bretylium—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000904	0.0013	CcSEcCtD
Bretylium—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000903	0.0013	CcSEcCtD
Bretylium—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000902	0.0013	CcSEcCtD
Bretylium—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000899	0.0013	CcSEcCtD
Bretylium—Dizziness—Propofol—epilepsy syndrome	0.000894	0.00129	CcSEcCtD
Bretylium—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000893	0.00129	CcSEcCtD
Bretylium—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000892	0.00129	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000886	0.0065	CbGpPWpGaD
Bretylium—Vertigo—Valproic Acid—epilepsy syndrome	0.000885	0.00128	CcSEcCtD
Bretylium—Dizziness—Midazolam—epilepsy syndrome	0.000874	0.00126	CcSEcCtD
Bretylium—Abdominal pain—Clonazepam—epilepsy syndrome	0.000873	0.00126	CcSEcCtD
Bretylium—Body temperature increased—Clonazepam—epilepsy syndrome	0.000873	0.00126	CcSEcCtD
Bretylium—Body temperature increased—Phenytoin—epilepsy syndrome	0.000867	0.00125	CcSEcCtD
Bretylium—Nausea—Acetazolamide—epilepsy syndrome	0.000864	0.00125	CcSEcCtD
Bretylium—Dizziness—Levetiracetam—epilepsy syndrome	0.000863	0.00125	CcSEcCtD
Bretylium—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000863	0.00125	CcSEcCtD
Bretylium—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000862	0.00125	CcSEcCtD
Bretylium—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000862	0.00125	CcSEcCtD
Bretylium—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000862	0.00124	CcSEcCtD
Bretylium—Vomiting—Propofol—epilepsy syndrome	0.000859	0.00124	CcSEcCtD
Bretylium—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000856	0.00124	CcSEcCtD
Bretylium—Conjunctivitis—Topiramate—epilepsy syndrome	0.000855	0.00123	CcSEcCtD
Bretylium—Hypertension—Valproic Acid—epilepsy syndrome	0.00085	0.00123	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000848	0.00623	CbGpPWpGaD
Bretylium—Vomiting—Midazolam—epilepsy syndrome	0.000841	0.00121	CcSEcCtD
Bretylium—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00084	0.00121	CcSEcCtD
Bretylium—Anxiety—Valproic Acid—epilepsy syndrome	0.000836	0.00121	CcSEcCtD
Bretylium—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000834	0.0012	CcSEcCtD
Bretylium—Dizziness—Fosphenytoin—epilepsy syndrome	0.000833	0.0012	CcSEcCtD
Bretylium—Vomiting—Levetiracetam—epilepsy syndrome	0.00083	0.0012	CcSEcCtD
Bretylium—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000827	0.00119	CcSEcCtD
Bretylium—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000827	0.00119	CcSEcCtD
Bretylium—Diarrhoea—Diazepam—epilepsy syndrome	0.000827	0.00119	CcSEcCtD
Bretylium—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000827	0.00119	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000827	0.00607	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000827	0.00607	CbGpPWpGaD
Bretylium—Dizziness—Vigabatrin—epilepsy syndrome	0.000812	0.00117	CcSEcCtD
Bretylium—Confusional state—Valproic Acid—epilepsy syndrome	0.000811	0.00117	CcSEcCtD
Bretylium—Bradycardia—Topiramate—epilepsy syndrome	0.000803	0.00116	CcSEcCtD
Bretylium—Nausea—Propofol—epilepsy syndrome	0.000803	0.00116	CcSEcCtD
Bretylium—Vomiting—Fosphenytoin—epilepsy syndrome	0.000801	0.00116	CcSEcCtD
Bretylium—Diarrhoea—Felbamate—epilepsy syndrome	0.000801	0.00116	CcSEcCtD
Bretylium—Vertigo—Pregabalin—epilepsy syndrome	0.0008	0.00116	CcSEcCtD
Bretylium—Abdominal pain—Lamotrigine—epilepsy syndrome	0.0008	0.00115	CcSEcCtD
Bretylium—Body temperature increased—Lamotrigine—epilepsy syndrome	0.0008	0.00115	CcSEcCtD
Bretylium—Dizziness—Diazepam—epilepsy syndrome	0.0008	0.00115	CcSEcCtD
Bretylium—Syncope—Pregabalin—epilepsy syndrome	0.000799	0.00115	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000789	0.00579	CbGpPWpGaD
Bretylium—Nausea—Midazolam—epilepsy syndrome	0.000785	0.00113	CcSEcCtD
Bretylium—Diarrhoea—Zonisamide—epilepsy syndrome	0.000784	0.00113	CcSEcCtD
Bretylium—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000783	0.00113	CcSEcCtD
Bretylium—Vomiting—Vigabatrin—epilepsy syndrome	0.000781	0.00113	CcSEcCtD
Bretylium—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000777	0.00112	CcSEcCtD
Bretylium—Nausea—Levetiracetam—epilepsy syndrome	0.000775	0.00112	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—ABCC2—epilepsy syndrome	0.000774	0.00568	CbGpPWpGaD
Bretylium—Dizziness—Felbamate—epilepsy syndrome	0.000774	0.00112	CcSEcCtD
Bretylium—Hypertension—Pregabalin—epilepsy syndrome	0.000769	0.00111	CcSEcCtD
Bretylium—Vomiting—Diazepam—epilepsy syndrome	0.000769	0.00111	CcSEcCtD
Bretylium—Dizziness—Zonisamide—epilepsy syndrome	0.000758	0.00109	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000756	0.00555	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000756	0.00555	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000756	0.00555	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000756	0.00555	CbGpPWpGaD
Bretylium—Anxiety—Pregabalin—epilepsy syndrome	0.000756	0.00109	CcSEcCtD
Bretylium—Diarrhoea—Clonazepam—epilepsy syndrome	0.000755	0.00109	CcSEcCtD
Bretylium—Diarrhoea—Phenytoin—epilepsy syndrome	0.00075	0.00108	CcSEcCtD
Bretylium—Nausea—Fosphenytoin—epilepsy syndrome	0.000748	0.00108	CcSEcCtD
Bretylium—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000746	0.00108	CcSEcCtD
Bretylium—Vomiting—Felbamate—epilepsy syndrome	0.000744	0.00107	CcSEcCtD
Bretylium—Vertigo—Gabapentin—epilepsy syndrome	0.000734	0.00106	CcSEcCtD
Bretylium—Confusional state—Pregabalin—epilepsy syndrome	0.000733	0.00106	CcSEcCtD
Bretylium—Flushing—Topiramate—epilepsy syndrome	0.000732	0.00106	CcSEcCtD
Bretylium—Syncope—Gabapentin—epilepsy syndrome	0.000732	0.00106	CcSEcCtD
Bretylium—Dizziness—Clonazepam—epilepsy syndrome	0.00073	0.00105	CcSEcCtD
Bretylium—Nausea—Vigabatrin—epilepsy syndrome	0.00073	0.00105	CcSEcCtD
Bretylium—Vomiting—Zonisamide—epilepsy syndrome	0.000728	0.00105	CcSEcCtD
Bretylium—Dizziness—Phenytoin—epilepsy syndrome	0.000725	0.00105	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000722	0.0053	CbGpPWpGaD
Bretylium—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000721	0.00104	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC6A1—epilepsy syndrome	0.00072	0.00528	CbGpPWpGaD
Bretylium—Nausea—Diazepam—epilepsy syndrome	0.000718	0.00104	CcSEcCtD
Bretylium—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000718	0.00104	CcSEcCtD
Bretylium—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000717	0.00103	CcSEcCtD
Bretylium—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000716	0.00103	CcSEcCtD
Bretylium—Shock—Pregabalin—epilepsy syndrome	0.000715	0.00103	CcSEcCtD
Bretylium—Hypertension—Gabapentin—epilepsy syndrome	0.000705	0.00102	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—IL1B—epilepsy syndrome	0.000704	0.00517	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000704	0.00517	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000704	0.00517	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000703	0.00516	CbGpPWpGaD
Bretylium—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000703	0.00101	CcSEcCtD
Bretylium—Vomiting—Clonazepam—epilepsy syndrome	0.000702	0.00101	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000699	0.00513	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000699	0.00513	CbGpPWpGaD
Bretylium—Vomiting—Phenytoin—epilepsy syndrome	0.000697	0.00101	CcSEcCtD
Bretylium—Nausea—Felbamate—epilepsy syndrome	0.000695	0.001	CcSEcCtD
Bretylium—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000694	0.001	CcSEcCtD
Bretylium—Anxiety—Gabapentin—epilepsy syndrome	0.000693	0.001	CcSEcCtD
Bretylium—Dizziness—Carbamazepine—epilepsy syndrome	0.000692	0.001	CcSEcCtD
Bretylium—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000692	0.000999	CcSEcCtD
Bretylium—Nausea—Zonisamide—epilepsy syndrome	0.00068	0.000982	CcSEcCtD
Bretylium—Confusional state—Gabapentin—epilepsy syndrome	0.000672	0.00097	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000671	0.00492	CbGpPWpGaD
Bretylium—Dizziness—Lamotrigine—epilepsy syndrome	0.000669	0.000966	CcSEcCtD
Bretylium—Vomiting—Carbamazepine—epilepsy syndrome	0.000666	0.000961	CcSEcCtD
Bretylium—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000662	0.000957	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000661	0.00485	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000657	0.000949	CcSEcCtD
Bretylium—Nausea—Clonazepam—epilepsy syndrome	0.000656	0.000947	CcSEcCtD
Bretylium—Shock—Gabapentin—epilepsy syndrome	0.000656	0.000947	CcSEcCtD
Bretylium—Nausea—Phenytoin—epilepsy syndrome	0.000651	0.000941	CcSEcCtD
Bretylium—Dyspnoea—Pregabalin—epilepsy syndrome	0.000648	0.000936	CcSEcCtD
Bretylium—Nausea—Oxcarbazepine—epilepsy syndrome	0.000648	0.000936	CcSEcCtD
Bretylium—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000644	0.00093	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000644	0.00473	CbGpPWpGaD
Bretylium—Vomiting—Lamotrigine—epilepsy syndrome	0.000643	0.000929	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000643	0.00472	CbGpPWpGaD
Bretylium—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000635	0.000918	CcSEcCtD
Bretylium—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000635	0.000918	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000623	0.00457	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000623	0.00457	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000623	0.00457	CbGpPWpGaD
Bretylium—Nausea—Carbamazepine—epilepsy syndrome	0.000622	0.000898	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000619	0.00454	CbGpPWpGaD
Bretylium—Vertigo—Topiramate—epilepsy syndrome	0.000617	0.000891	CcSEcCtD
Bretylium—Syncope—Topiramate—epilepsy syndrome	0.000616	0.00089	CcSEcCtD
Bretylium—Loss of consciousness—Topiramate—epilepsy syndrome	0.000604	0.000872	CcSEcCtD
Bretylium—Nausea—Lamotrigine—epilepsy syndrome	0.000601	0.000868	CcSEcCtD
Bretylium—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000599	0.000865	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000598	0.00439	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000598	0.00439	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000598	0.00439	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000594	0.000858	CcSEcCtD
Bretylium—Dyspnoea—Gabapentin—epilepsy syndrome	0.000594	0.000858	CcSEcCtD
Bretylium—Hypertension—Topiramate—epilepsy syndrome	0.000593	0.000856	CcSEcCtD
Bretylium—Anxiety—Topiramate—epilepsy syndrome	0.000583	0.000842	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000575	0.00422	CbGpPWpGaD
Bretylium—Abdominal pain—Pregabalin—epilepsy syndrome	0.000575	0.00083	CcSEcCtD
Bretylium—Body temperature increased—Pregabalin—epilepsy syndrome	0.000575	0.00083	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000573	0.00421	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.00057	0.00418	CbGpPWpGaD
Bretylium—Confusional state—Topiramate—epilepsy syndrome	0.000565	0.000816	CcSEcCtD
Bretylium—Shock—Topiramate—epilepsy syndrome	0.000552	0.000797	CcSEcCtD
Bretylium—Diarrhoea—Valproic Acid—epilepsy syndrome	0.00055	0.000794	CcSEcCtD
Bretylium—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000549	0.000793	CcSEcCtD
Bretylium—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000545	0.000787	CcSEcCtD
Bretylium—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000542	0.000783	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000533	0.00391	CbGpPWpGaD
Bretylium—Dizziness—Valproic Acid—epilepsy syndrome	0.000532	0.000768	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000527	0.00387	CbGpPWpGaD
Bretylium—Abdominal pain—Gabapentin—epilepsy syndrome	0.000527	0.000761	CcSEcCtD
Bretylium—Body temperature increased—Gabapentin—epilepsy syndrome	0.000527	0.000761	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC2A1—epilepsy syndrome	0.00052	0.00382	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TNF—epilepsy syndrome	0.000511	0.00375	CbGpPWpGaD
Bretylium—Vomiting—Valproic Acid—epilepsy syndrome	0.000511	0.000738	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000509	0.00374	CbGpPWpGaD
Bretylium—Dyspnoea—Topiramate—epilepsy syndrome	0.0005	0.000722	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000498	0.00365	CbGpPWpGaD
Bretylium—Diarrhoea—Pregabalin—epilepsy syndrome	0.000497	0.000718	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HBEGF—epilepsy syndrome	0.000489	0.00359	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000487	0.00358	CbGpPWpGaD
Bretylium—Dizziness—Pregabalin—epilepsy syndrome	0.000481	0.000694	CcSEcCtD
Bretylium—Nausea—Valproic Acid—epilepsy syndrome	0.000478	0.000689	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000475	0.00349	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000472	0.00346	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000472	0.00346	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000472	0.00346	CbGpPWpGaD
Bretylium—Vomiting—Pregabalin—epilepsy syndrome	0.000462	0.000667	CcSEcCtD
Bretylium—Feeling abnormal—Topiramate—epilepsy syndrome	0.000462	0.000667	CcSEcCtD
Bretylium—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000458	0.000662	CcSEcCtD
Bretylium—Diarrhoea—Gabapentin—epilepsy syndrome	0.000456	0.000658	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000454	0.00333	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00045	0.00331	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00045	0.00331	CbGpPWpGaD
Bretylium—Body temperature increased—Topiramate—epilepsy syndrome	0.000443	0.00064	CcSEcCtD
Bretylium—Abdominal pain—Topiramate—epilepsy syndrome	0.000443	0.00064	CcSEcCtD
Bretylium—Dizziness—Gabapentin—epilepsy syndrome	0.000441	0.000636	CcSEcCtD
Bretylium—Nausea—Pregabalin—epilepsy syndrome	0.000432	0.000623	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HMOX1—epilepsy syndrome	0.000428	0.00314	CbGpPWpGaD
Bretylium—Vomiting—Gabapentin—epilepsy syndrome	0.000424	0.000612	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000404	0.00296	CbGpPWpGaD
Bretylium—Nausea—Gabapentin—epilepsy syndrome	0.000396	0.000572	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000385	0.00283	CbGpPWpGaD
Bretylium—Diarrhoea—Topiramate—epilepsy syndrome	0.000384	0.000554	CcSEcCtD
Bretylium—Dizziness—Topiramate—epilepsy syndrome	0.000371	0.000535	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000367	0.00269	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000358	0.00263	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000358	0.00263	CbGpPWpGaD
Bretylium—Vomiting—Topiramate—epilepsy syndrome	0.000356	0.000515	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000341	0.0025	CbGpPWpGaD
Bretylium—Nausea—Topiramate—epilepsy syndrome	0.000333	0.000481	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000328	0.00241	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000327	0.0024	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000327	0.0024	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000327	0.0024	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000327	0.0024	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000317	0.00233	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000314	0.00231	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000304	0.00223	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000304	0.00223	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.00029	0.00213	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000286	0.0021	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000278	0.00204	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000268	0.00197	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000267	0.00196	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000259	0.0019	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000259	0.0019	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000248	0.00182	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.00023	0.00169	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000211	0.00155	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000205	0.00151	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.00019	0.0014	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000175	0.00128	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000167	0.00122	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000162	0.00119	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000137	0.00101	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000136	0.000997	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000132	0.000966	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.23e-05	0.000604	CbGpPWpGaD
